Santa Ana Bio develops precision antibody therapies that target disease-driving immune cells and pathways in autoimmune and inflammatory disorders.

Products & media

SAB01

Investigational KIT/Siglec-6 bispecific antibody in Phase 1, designed to selectively deplete mast cells in allergic and inflammatory diseases.

SAB06

Preclinical multispecific antibody program combining inflammatory pathways, including TL1A and IL-23, for inflammatory bowel disease and related conditions.

SAB05

Preclinical CD40-targeted glucocorticoid antibody-drug conjugate designed to combine immune blockade with localized steroid delivery at inflamed tissue.

Team

3 people across company lists

Founders

2 people

List
Ansu Satpathy2022-09
Richard Flavell

Current Affiliates

1 person

List
Peter Emtage

Jobs

See all jobs for Santa Ana Bio here.

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Leads

Participating Firms

Angels